R.-P. Perng
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Pleural and Pulmonary Diseases
Papers in
-
- Lung Cancer Treatments and Mutations 15
- Lung Cancer Diagnosis and Treatment 7
- Pleural and Pulmonary Diseases 6
- Oncology 22
- Lung Cancer Research Studies 9
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 4
- Co-authors
- Chun‐Ming Tsai (8 shared papers)Adi F. Gazdar (3 shared papers)Tetsuya Mitsudomi (2 shared papers)Yan-Ming Chen (6 shared papers)Jacqueline Whang‐Peng (14 shared papers)C.-M. Tsai (6 shared papers)Li‐Hwa Wu (2 shared papers)Chikabumi Kadoyama (1 shared paper)
- Journals
- Japanese Journal of Clinical Oncology (8 papers)Journal of Clinical Oncology (4 papers)JNCI Journal of the National Cancer Institute (3 papers)Lung Cancer (3 papers)Respiratory Medicine (1 paper)
- Partner nations
- TaiwanUnited StatesFrance
In The Last Decade
R.-P. Perng
44 papers receiving 913 citations
Peers
Comparison fields: 5 of 74
- Oncology 535
- Pulmonary and Respiratory Medicine 440
- Radiology, Nuclear Medicine and Imaging 139
- Cancer Research 82
- Microbiology 4
Countries citing papers authored by R.-P. Perng
This map shows the geographic impact of R.-P. Perng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.-P. Perng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.-P. Perng more than expected).
Fields of papers citing papers by R.-P. Perng
This network shows the impact of papers produced by R.-P. Perng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.-P. Perng. The network helps show where R.-P. Perng may publish in the future.
Co-authors
The 25 scholars most cited alongside R.-P. Perng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 142 | |
| 2 | 1996 | 89 | |
| 3 | 1995 | 78 | |
| 4 | Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells. | 1996 | 74 |
| 5 | 2002 | 49 | |
| 6 | 2010 | 47 | |
| 7 | Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients. | 1998 | 44 |
| 8 | 1997 | 42 | |
| 9 | 1996 | 40 | |
| 10 | 1996 | 34 | |
| 11 | 1996 | 30 | |
| 12 | 1992 | 26 | |
| 13 | 1998 | 24 | |
| 14 | 1997 | 22 | |
| 15 | 2002 | 22 | |
| 16 | Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells. | 1995 | 22 |
| 17 | 1996 | 21 | |
| 18 | Cutaneous metastasis of lung cancer: an ominous prognostic sign. | 1996 | 19 |
| 19 | Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines. | 1993 | 17 |
| 20 | 2002 | 15 |
About R.-P. Perng
R.-P. Perng is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Epidemiology, having authored 47 papers that have together received 950 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (9 papers), Lung Cancer Diagnosis and Treatment (7 papers), Pleural and Pulmonary Diseases (6 papers), Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (5 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Oncology (535 citations), Pulmonary and Respiratory Medicine (440 citations), Radiology, Nuclear Medicine and Imaging (139 citations), Cancer Research (82 citations) and Microbiology (4 citations). R.-P. Perng has collaborated with scholars based in Taiwan, United States and France. Frequent co-authors include Chun‐Ming Tsai, Adi F. Gazdar, Tetsuya Mitsudomi, Yan-Ming Chen, Jacqueline Whang‐Peng, C.-M. Tsai, Li‐Hwa Wu, Chikabumi Kadoyama, Kuang‐Yao Yang and Mien‐Chie Hung. Their work appears in journals such as Japanese Journal of Clinical Oncology, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, Lung Cancer and Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.